The medical equipment and technology distribution company, participated by Corpfin Capital, acquires Wacrees.
Palex began its accelerated growth phase in 2016 with the entry of Corpfin Capital. At the end of 2021 Fremman took a majority stake with Corpfin Capital, Ergon and the Palex management team continuing as minority partners.
With the incorporation of Wacress, Palex continues to lead the sector and reinforces its organic and inorganic growth plan through acquisitions of complementary companies. Palex will continue to focus on diversification in its product portfolio, innovation and minimally invasive treatments.